SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SARS and Avian Flu
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: SG who wrote (2644)10/13/2005 11:36:37 PM
From: Maurice Winn  Read Replies (1) of 4232
 
Tamiflu isn't very effective, as shown by the death rates so far. I'm sure doctors in Vietnam have heard of Tamiflu and could get it.

Without Tamiflu, I'd say we'll be looking at the initial 70% death rate. Or worse as even some of those probably had Tamiflu too.

With half the world dead, it's going to leave a LOT of room for the rest to breathe easy. No traffic jams on the way to work. Empty apartments everywhere, though I suppose they'll simply fill up as people spread out and the crowded places empty a little to fill in the gaps.

I wonder if there's data on "no-Tamiflu" cases so far. Plus, data on "treated with Tamiflu". Suggestion was that Tamiflu isn't very effective on H5N1. Which means the shortage of it won't matter quite as much.

Mqurice
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News